Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial
Titel:
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial
Auteur:
Conforti, Fabio Zucali, Paolo Andrea Pala, Laura Catania, Chiara Bagnardi, Vincenzo Sala, Isabella Della Vigna, Paolo Perrino, Matteo Zagami, Paola Corti, Chiara Stucchi, Sara Barberis, Massimo Guerini-Rocco, Elena Di Venosa, Benedetta De Vincenzo, Fabio Cordua, Nadia Santoro, Armando Giaccone, Giuseppe De Pas, Tommaso Martino